Detection and management of associated atherothrombotic locations in patients with a recent atherothrombotic ischemic stroke: Results of the DETECT survey

Cerebrovascular Diseases

Volumn 21, Issue 1-2, 2006, Pages 60-66

  Leys, D ^a   Woimant, F ^b   Ferrieres J ^c   Bauters, C ^a   Touboul, P J ^d   Guerillot M ^e   Herrmann, M A ^f   Priollet, P ^g  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Lariboisière ^*  (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

^d BICHAT HOSPITAL   (France)

^e SANOFI   (France)

^f BRISTOL MYERS SQUIBB   (United States)

^g SAINT JOSEPH HOSPITAL   (France)

Author keywords

Aortic atheroma; Atherothrombosis; Cerebral infarction; Myocardial infarction; Peripheral artery disease

Indexed keywords

ADULT; AGED; ARTICLE; ATHEROMA; BRAIN INFARCTION; CARDIOVASCULAR RISK; FEMALE; FRANCE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; NEUROLOGY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STROKE; THROMBOSIS; TIME SERIES ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CAROTID ARTERY THROMBOSIS; CEREBRAL INFARCTION; CORONARY ARTERIOSCLEROSIS; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS;

EID: 30944465827     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090004     Document Type: Article

References (10)

1. Hankey GJ, Warlow CP: Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Lancet 1999;354:1457-1463.
2. Leys D: Atherothrombosis: a major health burden. Cerebrovasc Dis 2001;11(suppl 2):1-4.
3. CAPRIE Steering Committee: A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-1339.
4. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ: Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004;364:331-337.
5. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
6. Bonita R, Beaglehole R: Recovery of motor function after stroke. Stroke 1988;19:1497-1500.
7. Leng GC, Fowkes FG, Lee AJ, Dunbar J, Housley E, Ruckley CV: Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ 1996;313:1440-1444.
8. Leys D, Kwiecinski H, Bogousslavsky J, Bath P, Brainin M, Diener HC, Kaste M, Sivenius J, Hennerici MG, Hacke W: Prevention. European Stroke Initiative. Cerebrovasc Dis 2004;17(suppl 2):15-29.
9. Woimant F, De Broucker T, Vassel P: Management of stroke in France. Results of 3 national surveys. Rev Neurol (Paris) 2003;159:543-551.
10. Priollet P, Mourad JJ, Cacoub P, Levesque H, Luizy F, Benelbaz J, Herrmann MA, Guerillot M, Blacher J: Peripheral arterial disease: what management practices for general practitioners? J Mal Vasc 2004;29:249-256.